Detalhe da pesquisa
1.
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet
; 395(10238): 1695-1704, 2020 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401715
2.
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.
Clin Infect Dis
; 52(4): 447-56, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21248066